In this issue:
N-acetylcysteine as an adjunctive treatment for bipolar depression
ENLIGHTEN-1 demonstrates efficacy of olanzapine/samidorphan in schizophrenia
Routine autoimmune encephalitis screening cost effective in first-episode psychosis
Is ECT efficacious for depressed patients with borderline personality disorder?
The prevalence and fiscal burden of depression in the US
Inpatient psychiatric telehealth during the COVID-19 pandemic
Antidepressant efficacy of the psychedelic psilocybin
Mental health impact of the COVID-19 pandemic in New Zealand
Increased risk of relapse with dose reduction of maintenance antipsychotics in schizophrenia
Response to adjunctive aripiprazole therapy in major depressive disorder
Please login below to download this issue (PDF)